Search Results 521-530 of 16968 for ozempic

1. Inebilizumab-cdon (intravenous route) - Side effects & uses - Mayo Clinic

   Inebilizumab-cdon injection is used to treat neuromyelitis optic spectrum disorder (NMOSD), a rare disorder that causes inflammation of the nerves of the eyes ...

2. Pembrolizumab And Ibrutinib In Treating Patients With Stage III-IV Melanoma That Cannot Be Removed By Surgery - Mayo Clinic

   Monoclonal antibodies, such as pembrolizumab, may interfere with the ability of tumor cells to grow and spread. Ibrutinib may stop the growth of tumor cells by ...

3. A Study To Evaluate The Safety, Tolerability, Drug/Body Interactions, And Activity Of Oradoxel For Patients With Advanced Malignancies - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

4. Breast cancer - Doctors and departments - Mayo Clinic

   Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.

5. Adenomyosis - Doctors and departments - Mayo Clinic

   Displaced endometrial tissue from adenomyosis can cause an enlarged uterus and painful, heavy periods.

6. Gastroenterology and Hepatology - Clinical trials

   [MUSIC PLAYING]. Joseph Sirven, M.D., Professor of Neurology, Mayo Clinic: Mayo's mission is about the patient. The patient comes first.

7. Pulmonary embolism - Doctors and departments - Mayo Clinic

   A blood clot blocks and stops blood flow to an artery in the lung. Often the clot starts in a leg and travels to the lung.

8. Ependymoma - Doctors and departments - Mayo Clinic

   Learn about this tumor that forms from ependymal cells in the brain and spinal cord. Treatments include surgery, radiation therapy and chemotherapy.

9. A Multi-center, Open-label Extension, Safety Study Of Mepolizumab In Subjects With Hypereosinophilic Syndrome (HES) From Study 200622 - Mayo Clinic

   About this study. This is an open-label extension study to Study 200622.In this study subjects from Study 200622 will be continued on 4-weekly dosing with ...

10. A Phase I/II Study of AZD0466 as Monotherapy or in Combination With Anticancer Agents in Advanced Non-Hodgkin Lymphoma - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...